Nathan J. Schloemer

Also affiliated with Medical College of Wisconsin

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity”.

Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity

Frontiers in Immunology(2023)10.3389/fimmu.2023.1225610

N/A

0.530DataRank · unranked

14 citations

Robyn A. A. Oldham, Archana Thakur, Mary Jo Rademacher, Ewa Kubicka, Theresa A. Dlugi +6 more

Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway

Oncotarget(2020)10.18632/oncotarget.27546

N/A

0DataRank · unranked

39 citations

Shunhua Lao, Nathan J. Schloemer, Jeffrey Knipstein, Robert Burns, Monica S. Thakar +2 more

Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies

Pediatric Blood & Cancer(2024)10.1002/pbc.31200

N/A

0DataRank · unranked

1 citations

Wei Xue, Amira Qumseya, Leo Y. Luo, Susan M. Hiniker, Timothy B. Lautz +4 more